These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23010947)

  • 41. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion.
    Sanjuan MA; Rao N; Lai KT; Gu Y; Sun S; Fuchs A; Fung-Leung WP; Colonna M; Karlsson L
    J Cell Biol; 2006 Mar; 172(7):1057-68. PubMed ID: 16567503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide.
    Chen L; Arora M; Yarlagadda M; Oriss TB; Krishnamoorthy N; Ray A; Ray P
    J Immunol; 2006 Aug; 177(4):2373-83. PubMed ID: 16887999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium.
    Trieu A; Bokil N; Dunn JA; Roberts TL; Xu D; Liew FY; Hume DA; Stacey KJ; Sweet MJ
    Immunol Cell Biol; 2009; 87(3):218-25. PubMed ID: 19048019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection.
    Welner RS; Pelayo R; Nagai Y; Garrett KP; Wuest TR; Carr DJ; Borghesi LA; Farrar MA; Kincade PW
    Blood; 2008 Nov; 112(9):3753-61. PubMed ID: 18552210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leukotriene B4 potentiates CpG signaling for enhanced cytokine secretion by human leukocytes.
    Gaudreault E; Gosselin J
    J Immunol; 2009 Aug; 183(4):2650-8. PubMed ID: 19620296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9.
    Hirata Y; Kurobe H; Higashida M; Fukuda D; Shimabukuro M; Tanaka K; Higashikuni Y; Kitagawa T; Sata M
    Atherosclerosis; 2013 Dec; 231(2):227-33. PubMed ID: 24267232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pylori-induced gastritis.
    Otani K; Tanigawa T; Watanabe T; Nadatani Y; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Biochem Biophys Res Commun; 2012 Sep; 426(3):342-9. PubMed ID: 22940550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction of Monomeric and Dimeric G-Quadruplex-Structured CpG Oligodeoxynucleotides for Enhanced Uptake and Activation in TLR9-Positive Macrophages.
    Liao W; Tan M; Kusamori K; Takakura Y; Nishikawa M
    Nucleic Acid Ther; 2020 Oct; 30(5):299-311. PubMed ID: 32559406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Down-regulation of TLR9 expression affects the maturation and function of murine bone marrow-derived dendritic cells induced by CpG.
    Ma L; Zhao G; Hua C; Li X; Zhao X; Sun L; Hou Y
    Cell Mol Immunol; 2009 Jun; 6(3):199-205. PubMed ID: 19567203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides.
    Inoue J; Aramaki Y
    Vaccine; 2007 Jan; 25(6):1007-13. PubMed ID: 17049678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
    Front Immunol; 2019; 10():179. PubMed ID: 30800129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides.
    Pan X; Li B; Kuang M; Liu X; Cen Y; Qin R; Ding G; Zheng J; Zhou H
    Int J Mol Sci; 2016 Feb; 17(2):242. PubMed ID: 26907260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus.
    Lindau D; Rönnefarth V; Erbacher A; Rammensee HG; Decker P
    Eur J Immunol; 2011 Mar; 41(3):669-81. PubMed ID: 21287547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytosolic Receptor Melanoma Differentiation-Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury.
    Gesuete R; Christensen SN; Bahjat FR; Packard AE; Stevens SL; Liu M; Salazar AM; Stenzel-Poore MP
    Stroke; 2016 Jan; 47(1):262-6. PubMed ID: 26564103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury.
    Stevens SL; Leung PY; Vartanian KB; Gopalan B; Yang T; Simon RP; Stenzel-Poore MP
    J Neurosci; 2011 Jun; 31(23):8456-63. PubMed ID: 21653850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury.
    David BT; Ratnayake A; Amarante MA; Reddy NP; Dong W; Sampath S; Heary RF; Elkabes S
    Neurobiol Dis; 2013 Jun; 54():194-205. PubMed ID: 23313320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IRF8 Impacts Self-Renewal of Hematopoietic Stem Cells by Regulating TLR9 Signaling Pathway of Innate Immune Cells.
    Li D; Zhang Y; Qiu Q; Wang J; Zhao X; Jiao B; Zhang X; Yu S; Xu P; Dan Y; Xiao X; Wang P; Liu M; Xia Z; Huang Z; Zhang R; Li J; Xie X; Zhang Y; Liu C; Liu P; Ren R
    Adv Sci (Weinh); 2021 Oct; 8(19):e2101031. PubMed ID: 34365741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC.
    Ramírez-Pineda JR; Fröhlich A; Berberich C; Moll H
    J Immunol; 2004 May; 172(10):6281-9. PubMed ID: 15128817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
    Ilvesaro JM; Merrell MA; Swain TM; Davidson J; Zayzafoon M; Harris KW; Selander KS
    Prostate; 2007 May; 67(7):774-81. PubMed ID: 17373717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.